AU7525496A - Methods and compositions comprising glut-2 and glut-2 chimeras - Google Patents
Methods and compositions comprising glut-2 and glut-2 chimerasInfo
- Publication number
- AU7525496A AU7525496A AU75254/96A AU7525496A AU7525496A AU 7525496 A AU7525496 A AU 7525496A AU 75254/96 A AU75254/96 A AU 75254/96A AU 7525496 A AU7525496 A AU 7525496A AU 7525496 A AU7525496 A AU 7525496A
- Authority
- AU
- Australia
- Prior art keywords
- glut
- chimeras
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54693495A | 1995-10-23 | 1995-10-23 | |
US546934 | 1995-10-23 | ||
PCT/US1996/017327 WO1997015668A2 (en) | 1995-10-23 | 1996-10-23 | Methods and compositions comprising glut-2 and glut-2 chimeras |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7525496A true AU7525496A (en) | 1997-05-15 |
Family
ID=24182621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75254/96A Abandoned AU7525496A (en) | 1995-10-23 | 1996-10-23 | Methods and compositions comprising glut-2 and glut-2 chimeras |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0857212A2 (en) |
AU (1) | AU7525496A (en) |
WO (1) | WO1997015668A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
WO2002043770A2 (en) * | 2000-12-01 | 2002-06-06 | Conforma Therapeutic Corporation | Homing peptide multimers, their preparation and uses |
US9777044B2 (en) | 2003-05-02 | 2017-10-03 | Centre National De La Recherche Scientifique (Cnrs) | GLUT-1 as a receptor for HTLV envelopes and its uses |
EP1648926B1 (en) | 2003-05-02 | 2013-07-03 | Centre National De La Recherche Scientifique (Cnrs) | Glut-1 as a receptor for htlv envelopes and its uses |
EP1586650A1 (en) * | 2004-04-16 | 2005-10-19 | ProBioGen AG | Intervention in the energy metabolism of eukaryotic cells for selection and increase of expression |
JP2009504183A (en) | 2005-08-15 | 2009-02-05 | ジェネンテック・インコーポレーテッド | Gene disruption and related compositions and methods |
BRPI1007376B1 (en) | 2009-01-09 | 2022-03-22 | Centre National De La Recherche Scientifique | New receptor-binding ligands and their use in the detection of cells of biological interest |
CN118401659A (en) | 2021-10-14 | 2024-07-26 | 阿西莫夫公司 | Integrase, landing gear architecture and engineered cells comprising same |
CN118696124A (en) | 2021-11-09 | 2024-09-24 | 阿西莫夫公司 | Stable production system for AAV vector production |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5358866A (en) * | 1991-07-03 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Cytosine deaminase negative selection system for gene transfer techniques and therapies |
US5366874A (en) * | 1992-01-02 | 1994-11-22 | Board Of Regents, The University Of Texas System | Molecular cloning and expression of biologically-active diphtheria toxin receptor |
CA2163427A1 (en) * | 1993-05-21 | 1994-12-08 | Stephen D. Lupton | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
WO1995000644A1 (en) * | 1993-06-28 | 1995-01-05 | Board Of Regents, The University Of Texas System | Vectors for genetically engineered cells that produce insulin in response to glucose |
-
1996
- 1996-10-23 WO PCT/US1996/017327 patent/WO1997015668A2/en not_active Application Discontinuation
- 1996-10-23 AU AU75254/96A patent/AU7525496A/en not_active Abandoned
- 1996-10-23 EP EP96937792A patent/EP0857212A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1997015668A2 (en) | 1997-05-01 |
WO1997015668A3 (en) | 1997-07-24 |
EP0857212A2 (en) | 1998-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3641597A (en) | Methods and compositions comprising r-ibuprofen | |
AU7564694A (en) | Erection-inducing methods and compositions | |
AU7323294A (en) | Perfluoroelastomeric compositions and methods | |
AU2230695A (en) | Slag-based well cementing compositions and methods | |
AU3767097A (en) | Shampoo compositions and method | |
AU7275098A (en) | Enhanced adenovirus-assisted transfection composition and method | |
AU4266596A (en) | Composition and use | |
AU3045395A (en) | Cosmetic composition | |
AU3308195A (en) | Antihypertriglyceridemic composition | |
AU2972597A (en) | Compositions and uses thereof | |
AU4254596A (en) | Cosmetic composition | |
AU2079397A (en) | Improved connectors and methods | |
AU1466095A (en) | Dermatologic composition | |
AU4542296A (en) | Antimicrobic composition and its use | |
AUPO976597A0 (en) | Method and composition (I) | |
AU9301998A (en) | Composition and methods using galectin-1 | |
AU4876397A (en) | Insecticidal compositions and methods | |
AU7525496A (en) | Methods and compositions comprising glut-2 and glut-2 chimeras | |
AU1841195A (en) | 1-beta -methyl-carbapenem, compositions containing same and methods of use | |
AU3200197A (en) | New composition and methods | |
AUPN137895A0 (en) | Composition and method | |
AU3634595A (en) | Bis-oxazolidines and their use | |
AU1614495A (en) | Chair | |
AU1129697A (en) | Modified polyalkadiene-containing compositions | |
AUPO982097A0 (en) | Methods and compositions for use therein |